Back in September of 2011, I mentioned in this blog post that one of Watson's first jobs outside of playing Jeopardy! was going to be in the healthcare industry.
Well, earlier today, WellPoint Inc. and Memorial Sloan-Kettering Cancer Center unveiled the first commercially developed Watson-based cognitive computing breakthroughs.
These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence-based medicine.
The American Cancer Society projects that 1.6 million new cancer cases will be diagnosed in the US this year alone. Studies suggest that the complexities associated with healthcare have caused one in five healthcare patients to receive a wrong or incomplete diagnosis.
These statistics, coupled with a data explosion of medical information that is doubling every five years, represents an unprecedented opportunity for the healthcare industry and next-generation cognitive computing systems to combine forces in new ways to improve how medicine is taught, practiced, and paid for.
For more than a year now, IBM has partnered separately with WellPoint and Memorial Sloan-Kettering to train Watson in the areas of oncology and utilization management.
During this time, clinicians and technology experts spent thousands of hours "teaching" Watson how to process, analyze, and interpret the meaning of complex clinical information using natural language processing, all with the goal of helping to improve healthcare quality and efficiency.
"IBM's work with WellPoint and Memorial Sloan-Kettering Cancer Center represents a landmark collaboration in how technology and evidence-based medicine can transform the way in which healthcare is practiced," said Manoj Saxena, IBM General Manager, Watson Solutions (see my interview with Manoj at last fall's InterConnect event in Singapore further down in the post).
"These breakthrough capabilities bring forward the first in a series of Watson-based technologies, which exemplifies the value of applying big-data and analytics and cognitive computing to tackle the industries' most pressing challenges."
Evidence-based medicine: Addressing oncology issues by quickly assimilating massive amounts of medical information
To date, Watson has ingested more than 600,000 pieces of medical evidence, 2 million pages of text from 42 medical journals and clinical trials in the area of oncology research.
Watson has the power to sift through 1.5 million patient records representing decades of cancer treatment history, such as medical records and patient outcomes, and provide to physicians evidence-based treatment options, all in a matter of seconds.
In less than a year, Memorial Sloan-Kettering has immersed Watson in the complexities of cancer and the explosion of genetic research, which has set the stage for changing care practices for many cancer patients with highly specialized treatments based on their personal genetic tumor type.
Starting with 1,500 lung cancer cases, Memorial Sloan-Kettering clinicians and analysts are training Watson to extract and interpret physician notes, lab results, and clinical research, while sharing its profound expertise and experiences in treating hundreds of thousands of patients with cancer.
"It can take years for the latest developments in oncology to reach all practice settings. The combination of transformational technologies found in Watson with our cancer analytics and decision-making process has the potential to revolutionize the accessibility of information for the treatment of cancer in communities across the country and around the world," said Craig B. Thompson, MD, President of Memorial Sloan-Kettering Cancer Center. "Ultimately, we expect this comprehensive, evidence-based approach will profoundly enhance cancer care by accelerating the dissemination of practice-changing research at an unprecedented pace."
The Maine Center for Cancer Medicine and WESTMED Medical Group are the first two early adopters of the capability. Their oncologists will begin testing the product and providing feedback to WellPoint, IBM, and Memorial Sloan-Kettering to improve usability.
Speeding patient care through WellPoint's utilization management pilot
Throughout WellPoint's utilization management pilot, Watson absorbed more than 25,000 test case scenarios and 1,500 real-life cases and gained the ability to interpret the meaning and analyze queries in the context of complex medical data and human and natural language, including doctor's notes, patient records, medical annotations, and clinical feedback.
In addition, more than 14,700 hours of hands-on training was spent by nurses who meticulously trained Watson. Watson continues to learn while on the job, much like a medical resident, while working with the WellPoint nurses who originally conducted its training.
Watson started processing common medical procedure requests by providers for members in WellPoint-affiliated health plans in December and was expanded to include five provider offices in the Midwest. Watson will serve as a powerful tool to accelerate the review process between a patient's physician and their health plan.
"The healthcare industry must drive transformation through innovation, including harnessing the latest technology that will ultimately benefit the healthcare consumer," said Lori Beer, WellPoint's executive vice president of Specialty Businesses and Information Technology. "We believe that WellPoint's data, knowledge, and extensive provider network, combined with the IBM Watson technology and Memorial Sloan-Kettering's oncological expertise, can drive this transformation."
Watson-powered health innovations
As a result, IBM, Memorial Sloan-Kettering, and WellPoint are introducing the first commercial products based on Watson. These innovations represent a breakthrough in how medical professionals can apply advances in analytics and natural language processing to big-data, combined with the clinical knowledge base, including genomic data, in order to create evidence-based decision support systems.
These Watson-based systems are designed to assist doctors, researchers, medical centers, and insurance carriers and ultimately enhance the quality and speed of care. The new products include the Interactive Care Insights for Oncology, powered by Watson, in collaboration with IBM, Memorial Sloan-Kettering, and WellPoint.
The WellPoint Interactive Care Guide and Interactive Care Reviewer, powered by Watson, designed for utilization management in collaboration with WellPoint and IBM.
New interactive care insights for oncology
The cognitive systems use insights gleaned from the deep experience of Memorial Sloan-Kettering clinicians to provide individualized treatment options based on patient's medical information and the synthesis of a vast array of updated and vetted treatment guidelines and published research.
A first-of-its-kind Watson-based advissr, available through the cloud, is expected to assist medical professionals and researchers by helping to identify individualized treatment options for patients with cancer, starting with lung cancer.
Provides users with a detailed record of the data and information used to reach the treatment options. Oncologists located anywhere can remotely access detailed treatment options based on updated research that will help them decide how best to care for an individual patient.
New WellPoint interactive care guide and interactive care reviewer
Delivers the first Watson-based cognitive computing system anticipated to streamline the review processes between a patient's physician and their health plan, potentially speeding approvals from utilization management professionals, reducing waste, and helping ensure evidence-based care is provided.
Expected to accelerate accepted testing and treatment by shortening pre-authorization approval time, which means that patients are moving forward with the first crucial step toward treatment more quickly.
Analyzes treatment requests and matches them to WellPoint's medical policies and clinical guidelines to present consistent, evidence-based responses for clinical staff to review, in the anticipation of providing faster, better informed decisions about a patient's care.
WellPoint has deployed Interactive Care Reviewer to a select number of providers in the Midwest and believes more than 1,600 providers will be using the product by the end of the year.
Watson: Then and now
The IBM Watson system gained fame by beating human contestants on the television quiz show Jeopardy! almost two years ago. Since that time, Watson has evolved from a first-of-a-kind status to a commercial cognitive computing system, gaining a 240 percent improvement in system performance and a reduction in the system's physical requirements by 75 percent, and can now be run on a single Power 750 server.
The transformational technology, named after IBM founder Thomas J. Watson, was developed in IBM's Research Labs. Using advances in natural language processing and analytics, the Watson technology can process information similar to the way people think, representing a significant shift in the ability for organizations to quickly analyze, understand, and respond to vast amounts of big-data.
The ability to use Watson to answer complex questions posed in natural language with speed, accuracy, and confidence has enormous potential to improve decision making across a variety of industries from healthcare to retail, telecommunications, and financial services.
You can also follow Watson on Facebook here and via Twitter at hashtag #IBMWatson.
And below, you can see the aforementioned video where I interviewed IBM Watson general manager Manoj Saxena about Watson's future at last year's IBM InterConnect event.
Todd, more people would give their information over gladly if there was news about the benefits of doing so for projects such as this. Instead, we hear the nightmares over and over again which just reconfirms our worst fears are constants in the world we live in.
People who know me know I'm a bit of a privacy hawk, and have been for over a decade now. But I would agree -- this is an opportunity where Watson can add real value and save lives by helping become that doctor's assistant that can keep physicians up on the latest medical journals and overall knowledge, but only if patients are willing to allow those personal records to become anonymized and included in the likes of this system I was discussing in the blog post.
Watson has the power to sift through 1.5 million patient records representing decades of cancer treatment history, such as medical records and patient outcomes, and provide to physicians evidence-based treatment options, all in a matter of seconds.
Patient records and privacy are the kinds of issues we talk about here at IE. Concerns over misuse of information abound. Here's a case where I would hope -- really and truly hope, that the possibility of violations of security are seen as a small price to pay for the myriad of benefits that can come from aggregating large amounts of data to treat and cure patients on a broad scope.
The ThinkerNet does not reflect the views of TechWeb. The ThinkerNet is an informal means of communication to members and visitors of the Internet Evolution site. Individual authors are chosen by Internet Evolution to blog. Neither Internet Evolution nor TechWeb assume responsibility for comments, claims, or opinions made by authors and ThinkerNet bloggers. They are no substitute for your own research and should not be relied upon for trading or any other purpose.
The IBM Smarter Commerce Global Summit in Monaco kicked into high gear today, and we've already begun to see news emerging from that lovely city-state by the sea.
So here we are, the last day of the 2013 US Open Golf Championship at Merion, and Phil Mickelson -- who has been a US Open runner-up five times now but never taken the trophy -- is right up there at the top of the leaderboard.
The last time I saw Monaco, I was heading from Milan to Nice in a car-full of IBM colleagues with whom I was on a two-week long business trip throughout Europe.
Big-data and analytics tools enable marketers to understand customers as individuals, identifying unmet needs and addressing each customer as a "segment of one," says John Kennedy, VP corporate marketing, IBM.
Edmunds separates customers into segments based on the info it collects on its site and from partners, and uses that to push out custom content, said Brian Baron, director of business analytics for Edmunds.com, at Predictive Analytics Innovation Summit.
The automotive website uses propensity modeling to target ads and customer registration forms, said Brian Baron, director of business analytics for Edmunds.com, at Predictive Analytics Innovation Summit.
Big-data has become a big point of emphasis for many businesses. While the technology is available to deploy these applications, the needed personnel often is not. As a result, analytic engineers' salaries have blown past the six-figure mark, and hiring these experts has become a challenge for IT managers.
The automotive website uses propensity modeling of customer behavior to convert more site visitors into leads, says Brian Baron, director of business analytics, in an interview at the Predictive Analytics Innovation Summit.
The medical instruments manufacturer looks to metrics to quantify its social business engagement, according to Mary Maida, Medtronic lead information solutions manager. Internet Evolution editor in chief Mitch Wagner interviewed Maida at the E2 Innovate conference.
Network complexity, cloud-based architectures, the explosion of apps, and the growth of bandwidth needs are among the reasons enterprises need to improve insight into traffic and data.
Big-data and analytics tools enable marketers to understand customers as individuals, identifying unmet needs and addressing each customer as a "segment of one," says John Kennedy, VP corporate marketing, IBM.
New York's Metropolitan Transit Authority is conducting a pilot test of digital kiosks to guide subway users to where they want to go more efficiently and at lower cost.
The whole Amazon.reader debate is a double-stupid. It's stupid to think that there's any e-book buyer who doesn't know Amazon's URL, and it was stupider to let ICANN launch the whole free-form TLD initiative to start with.
While NFC's original goal was to enhance mobile commerce applications, it is finding its way into a number of other uses, which is creating both opportunity as well as challenges for IT departments.
Enterprises would like to move to cloud computing but are hesitant because they are concerned about providers’ ability to secure company data. Here are some tips that help to ensure that if breaches occur, the business is not left holding the bag.
Edmunds separates customers into segments based on the info it collects on its site and from partners, and uses that to push out custom content, said Brian Baron, director of business analytics for Edmunds.com, at Predictive Analytics Innovation Summit.
The IBM Smarter Commerce Global Summit in Monaco kicked into high gear today, and we've already begun to see news emerging from that lovely city-state by the sea.
Expert Integrated Systems: Changing the Experience & Economics of IT In this e-book, we take an in-depth look at these expert integrated systems -- what they are, how they work, and how they have the potential to help CIOs achieve dramatic savings while restoring IT's role as business innovator. READ THIS eBOOK
your weekly update of news, analysis, and
opinion from Internet Evolution - FREE! REGISTER HERE
Wanted! Site Moderators Internet Evolution is looking for a handful of readers to help moderate the message boards on our site – as well as engaging in high-IQ conversation with the industry mavens on our thinkerNet blogosphere. The job comes with various perks, bags of kudos, and GIANT bragging rights. Interested?
To save this item to your list of favorite Internet Evolution content so you can find it later in your Profile page, click the "Save It" button next to the item.
Email This
